
Benjamin L. Lebron
Examiner (ID: 7336, Phone: (571)272-0475 , Office: P/1777 )
| Most Active Art Unit | 1777 |
| Art Unit(s) | 1777, 1773 |
| Total Applications | 617 |
| Issued Applications | 402 |
| Pending Applications | 48 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10044381
[patent_doc_number] => 09084764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Epidermal cooling'
[patent_app_type] => utility
[patent_app_number] => 13/587445
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5243
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587445 | Epidermal cooling | Aug 15, 2012 | Issued |
Array
(
[id] => 8853197
[patent_doc_number] => 20130142872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'EMP2: Ethyl-Methyl, di Methyl, tri Methyl Pyruvate Acid Esters: A Tool for Regulating HbA1c and a Riboswitch Activator'
[patent_app_type] => utility
[patent_app_number] => 13/570454
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10048
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570454
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/570454 | EMP2: Ethyl-Methyl, di Methyl, tri Methyl Pyruvate Acid Esters: A Tool for Regulating HbA1c and a Riboswitch Activator | Aug 8, 2012 | Abandoned |
Array
(
[id] => 8495499
[patent_doc_number] => 20120294907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'TWO OR MORE SOLIDIFYING AGENT-CONTAINING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS'
[patent_app_type] => utility
[patent_app_number] => 13/567289
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17353
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13567289
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/567289 | TWO OR MORE SOLIDIFYING AGENT-CONTAINING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS | Aug 5, 2012 | Abandoned |
Array
(
[id] => 11210855
[patent_doc_number] => 09439873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Application aid'
[patent_app_type] => utility
[patent_app_number] => 14/236415
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5082
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236415
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236415 | Application aid | Aug 2, 2012 | Issued |
Array
(
[id] => 9642035
[patent_doc_number] => 20140220147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES'
[patent_app_type] => utility
[patent_app_number] => 14/236150
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13077
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236150
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236150 | PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES | Jul 30, 2012 | Abandoned |
Array
(
[id] => 9881635
[patent_doc_number] => 08968392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Method of inhibiting vascular intimal hyperplasia using stent'
[patent_app_type] => utility
[patent_app_number] => 13/561828
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13591
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561828 | Method of inhibiting vascular intimal hyperplasia using stent | Jul 29, 2012 | Issued |
Array
(
[id] => 9354807
[patent_doc_number] => 08673338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Methods of delivering pharmaceutical agents'
[patent_app_type] => utility
[patent_app_number] => 13/561998
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 23739
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561998 | Methods of delivering pharmaceutical agents | Jul 29, 2012 | Issued |
Array
(
[id] => 9843686
[patent_doc_number] => 08945597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Botanical insecticides'
[patent_app_type] => utility
[patent_app_number] => 13/526455
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4391
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526455
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526455 | Botanical insecticides | Jun 17, 2012 | Issued |
Array
(
[id] => 9634264
[patent_doc_number] => 20140212373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'Multi-Vinylsulfone Containing Molecule'
[patent_app_type] => utility
[patent_app_number] => 14/126725
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8569
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126725
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126725 | Multi-vinylsulfone containing molecule | Jun 14, 2012 | Issued |
Array
(
[id] => 9654028
[patent_doc_number] => 20140225033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'DIALYSIS PRECURSOR COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/128375
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3883
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128375
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128375 | Dialysis precursor composition | Jun 10, 2012 | Issued |
Array
(
[id] => 10121526
[patent_doc_number] => 09155873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Reusable intravaginal delivery device, system, and method'
[patent_app_type] => utility
[patent_app_number] => 13/473075
[patent_app_country] => US
[patent_app_date] => 2012-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 13210
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473075 | Reusable intravaginal delivery device, system, and method | May 15, 2012 | Issued |
Array
(
[id] => 10095404
[patent_doc_number] => 09131698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Biocidal compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/125095
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3040
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125095
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125095 | Biocidal compositions and methods of use | May 7, 2012 | Issued |
Array
(
[id] => 9375252
[patent_doc_number] => 08679512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Topical formulation comprising a corticosteroid as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 13/462245
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5859
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462245
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462245 | Topical formulation comprising a corticosteroid as active ingredient | May 1, 2012 | Issued |
Array
(
[id] => 8346955
[patent_doc_number] => 20120207877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'OLIGO-SACCHARIDE ENHANCED OAT-BASED DRINK FOR TREATING HYPERLIPIDAEMIA AND HYPERGLYCEMIA AND IMPROVING GASTROINTESTINAL FUNCTION AND PROCESS FOR PREPARING THE SAME BY TRI-ENZYME HYDROLYSIS AND MICRO-PARTICLE MILLING'
[patent_app_type] => utility
[patent_app_number] => 13/454367
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3538
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454367
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454367 | Oligo-saccharide enhanced oat-based drink for treating hyperlipidaemia and hyperglycemia and improving gastrointestinal function and process for preparing the same by tri-enzyme hydrolysis and micro-particle milling | Apr 23, 2012 | Issued |
Array
(
[id] => 10305517
[patent_doc_number] => 20150190517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'SYSTEMS AND METHODS FOR DELIVERING CROSS-LINKED HALYURONIC ACID INTO A PATIENT'
[patent_app_type] => utility
[patent_app_number] => 14/255961
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5028
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255961
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/255961 | SYSTEMS AND METHODS FOR DELIVERING CROSS-LINKED HALYURONIC ACID INTO A PATIENT | Apr 11, 2012 | Abandoned |
Array
(
[id] => 8358755
[patent_doc_number] => 20120213910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'Tablets with Site- and Time- Controlled Gastrointestinal Release of Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 13/421135
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6773
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421135
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421135 | Tablets with Site- and Time- Controlled Gastrointestinal Release of Active Ingredient | Mar 14, 2012 | Abandoned |
Array
(
[id] => 8265933
[patent_doc_number] => 20120165361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/412840
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11193
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412840
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412840 | DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME | Mar 5, 2012 | Abandoned |
Array
(
[id] => 8721297
[patent_doc_number] => 20130072514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'Sustained-Release Opioid Formulations and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/413334
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11792
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13413334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/413334 | Sustained-Release Opioid Formulations and Methods of Use | Mar 5, 2012 | Abandoned |
Array
(
[id] => 10510435
[patent_doc_number] => 09238008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-19
[patent_title] => 'Particles containing a growth factor, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/002435
[patent_app_country] => US
[patent_app_date] => 2012-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 4
[patent_no_of_words] => 11197
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002435 | Particles containing a growth factor, and uses thereof | Mar 4, 2012 | Issued |
Array
(
[id] => 8981674
[patent_doc_number] => 08512787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Process for manufacturing chewable dosage forms for drug delivery and products thereof'
[patent_app_type] => utility
[patent_app_number] => 13/396555
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4557
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/396555 | Process for manufacturing chewable dosage forms for drug delivery and products thereof | Feb 13, 2012 | Issued |